Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gel versus emulgel tretinoin + clindamycin for mild to moderate acne vulgaris
IRCT20150101020514N13Phase 2Completed
- Sponsor
- Jarf Andishan Navid Salamat
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tretinoin and clindamycin in acne vulgaris (2 arms), sponsored by Jarf Andishan Navid Salamat. Primary endpoint: Acne severity index. Started Dec 2021; status: completed.
02
Drugs
tretinoinclindamycin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20150101020514N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150101020514N13.